Stroke:皮质胆碱能通路严重病变预示缺血性卒中较差结局

2018-11-11 国际循环编辑部 国际循环

近期,Stroke发表的一项最新研究评估皮质胆碱能通路病变严重程度对急性缺血性卒中患者功能结局的影响。

近期,Stroke发表的一项最新研究评估皮质胆碱能通路病变严重程度对急性缺血性卒中患者功能结局的影响。

研究共计入选214例(70.9%)男性及88例(29.1%)女性急性缺血性卒中患者,采用脑核磁共振成像应用胆碱能通路高信号评分量表(CHIPS)评估皮质胆碱能通路中病变的严重程度,并记录梗死、白质病变及内侧颞叶萎缩等其他核磁共振成像结果。在卒中后3个月及6个月时采用日常生活活动(ADL)量表评估功能结局,采用改良Rankin量表评估残疾状况。

单因素分析显示,功能结局较差的患者年龄更大,更多为男性,入院时NIHSS评分更高,既往更多有卒中及感染并发症病史;更多存在皮质梗死、左侧皮质下梗死,梗死面积更大,内侧颞叶萎缩及脑室周围高信号更严重,CHIPS评分更高。多元回归分析中模型1显示,年龄及入院时NIHSS评分均是3个月时ADL更差的显著预测因素(R2=45.4%);年龄、入院时NIHSS评分及卒中亚型均是6个月时ADL较差的显著预测因素(R2=37.9%)。模型2显示,性别、既往卒中病史、入院时NIHSS评分、右侧皮质梗死、左侧皮质下梗死及CHIPS评分均是3个月时ADL较差的显著预测因素(R2=53.5% );入院时NIHSS评分、卒中亚型、CHIPS评分是6个月时ADL较差的显著预测因素( R2=40.2%)。校正混杂因素后,CHIPS评分还是3个月及6个月时改良Rankin量表评分较差的显著预测因素。即使排除中重度白质病变患者后,CHIPS评分较高仍与3个月及6个月时ADL及改良Rankin量表评分较差具有相关性。

上述结果显示,在急性缺血性卒中患者中,皮质胆碱能通路受损非常常见,皮质胆碱能通路病变预示功能结局较差。

原始出处:
Jian-Feng Qu, Yang-Kun Chen, Gen-Pei Luo, Jiang-Hao Zhao, et al. Severe Lesions Involving Cortical Cholinergic Pathways Predict Poorer Functional Outcome in Acute Ischemic Stroke. Stroke. Nov 2018.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1806287, encodeId=0608180628ef3, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Thu Jul 25 05:14:00 CST 2019, time=2019-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893118, encodeId=f5c61893118aa, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Nov 23 16:14:00 CST 2018, time=2018-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527404, encodeId=c461152e4048d, content=<a href='/topic/show?id=10b483495a2' target=_blank style='color:#2F92EE;'>#胆碱#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83495, encryptionId=10b483495a2, topicName=胆碱)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce6211859522, createdName=grace5704, createdTime=Tue Nov 13 06:14:00 CST 2018, time=2018-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026211, encodeId=2384102621166, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Sun Nov 11 18:14:00 CST 2018, time=2018-11-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1806287, encodeId=0608180628ef3, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Thu Jul 25 05:14:00 CST 2019, time=2019-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893118, encodeId=f5c61893118aa, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Nov 23 16:14:00 CST 2018, time=2018-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527404, encodeId=c461152e4048d, content=<a href='/topic/show?id=10b483495a2' target=_blank style='color:#2F92EE;'>#胆碱#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83495, encryptionId=10b483495a2, topicName=胆碱)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce6211859522, createdName=grace5704, createdTime=Tue Nov 13 06:14:00 CST 2018, time=2018-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026211, encodeId=2384102621166, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Sun Nov 11 18:14:00 CST 2018, time=2018-11-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1806287, encodeId=0608180628ef3, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Thu Jul 25 05:14:00 CST 2019, time=2019-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893118, encodeId=f5c61893118aa, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Nov 23 16:14:00 CST 2018, time=2018-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527404, encodeId=c461152e4048d, content=<a href='/topic/show?id=10b483495a2' target=_blank style='color:#2F92EE;'>#胆碱#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83495, encryptionId=10b483495a2, topicName=胆碱)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce6211859522, createdName=grace5704, createdTime=Tue Nov 13 06:14:00 CST 2018, time=2018-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026211, encodeId=2384102621166, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Sun Nov 11 18:14:00 CST 2018, time=2018-11-11, status=1, ipAttribution=)]
    2018-11-13 grace5704
  4. [GetPortalCommentsPageByObjectIdResponse(id=1806287, encodeId=0608180628ef3, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Thu Jul 25 05:14:00 CST 2019, time=2019-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893118, encodeId=f5c61893118aa, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Nov 23 16:14:00 CST 2018, time=2018-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527404, encodeId=c461152e4048d, content=<a href='/topic/show?id=10b483495a2' target=_blank style='color:#2F92EE;'>#胆碱#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83495, encryptionId=10b483495a2, topicName=胆碱)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce6211859522, createdName=grace5704, createdTime=Tue Nov 13 06:14:00 CST 2018, time=2018-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026211, encodeId=2384102621166, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Sun Nov 11 18:14:00 CST 2018, time=2018-11-11, status=1, ipAttribution=)]
    2018-11-11 健健

    卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!

    0

相关资讯

Stroke:高级神经影像学为卒中患者MT选择提供指导价值

在症状发作的第一个6小时内,临床医生可应用高级影像学技术指导可行机械血栓切除术(MT)治疗的缺血性卒中患者的选择。但越来越多的研究证据表明,高级神经影像学技术是非常有价值且与非时间依赖性的预后因素。

Neurology:TSH水平降低对急性缺血性卒中患者卒中后疲劳的预测作用

由此可见,甲状腺功能特征可预测急性缺血性卒中后的疲劳,提示神经内分泌反应可能在PSF中发挥作用。

Stroke:西酞普兰治疗对急性缺血性卒中患者的神经再生和血管保护效应

由此可见,早期西酞普兰治疗并未改善前6个月内非抑郁性缺血性卒中患者的功能恢复,尽管在分析人群中观察到临界统计学显著效应。治疗组之间心血管事件的风险相似,西酞普兰治疗耐受性良好。

2018 共识建议:脑出血,蛛网膜下腔出血以及急性缺血性卒中患者的目标温度管理

本文为采用改进的Delphi方法确定的针对:脑出血,蛛网膜下腔出血以及急性缺血性卒中患者合并非感染性发热的目标温度管理提出指导意见。

Neurology:NIHSS用于预测幕上和幕下急性缺血性卒中患者预后的临界值

由此可见,在符合溶栓条件的AIS患者中,NIHSS可能低估了幕上病变的临床严重程度,相比于恢复预后相似的幕上病变。当基线NIHSS评分超过6时,溶栓治疗对幕下AIS患者的卒中预后影响较小,因此应考虑采用额外治疗,如血管内治疗,来改善卒中预后。

Stroke:急性缺血性卒中患者血凝块迁移与静脉溶栓相关

由此可见,在EVT前桥接IVT的情况下,血凝块迁移的发生率显著增加,导致EVT无法接触血凝块的比例增加。